Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are ...

Anorexia nervosa is a serious mental health condition, characterized by restricted eating, fear of weight gain, and insidious ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

People you wouldn’t normally associate with drug use are self-treating by microdosing with psychedelics. Doctors need to be ...

The physiological power and biological value of brain-derived neurotrophic factor is so significant that it is often referred ...

A team from UNIGE, the Max Planck Institute for Molecular Physiology in Dortmund, and Heinrich Heine University in Düsseldorf ...

A new study published in Physiology & Behavior uncovers significant sensory implications of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications commonly prescribed for weight loss and ...

There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

In preclinical models, blocking this receptor shortly after injury significantly ... and Senior Lecturer in the RCSI Department of Physiology and Medical Physics, commented, "Traumatic brain ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential opportunity. Click for more on TECX.